Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masatoshi Sugeno

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Ecology|July 18, 2013
A semiparametric Bayesian method for detecting Allee effectsMasatoshi Sugeno, Stephan B Munch
Ecological Applications : a Publication of the Ecological Society of America|July 20, 2013
A semiparametric Bayesian approach to estimating maximum reproductive rates at low population sizesMasatoshi Sugeno, Stephan B Munch
Diabetes, Obesity & Metabolism|June 20, 2023
Safety/tolerability, efficacy and pharmacokinetics of 600-μg cotadutide in Japanese type 2 diabetes patients with a body mass index of 25 kg/m<sup>2</sup> or higher: A phase I, randomized, double-blind, placebo-controlled studyMichiko Asano, Akiko Sekikawa, Masatoshi Sugeno, et al.
Cancer Treatment and Research Communications|April 9, 2024
Safety, tolerability, pharmacokinetics, and antitumor activity of adavosertib in Japanese patients with advanced solid tumors: A phase I, open-label studyShunsuke Kondo, Yuki Katsuya, Kan Yonemori, et al.
The Oncologist|June 7, 2022
Phase I Study of Tremelimumab Monotherapy or in Combination With Durvalumab in Japanese Patients With Advanced Solid Tumors or Malignant MesotheliomaYutaka Fujiwara, Yasuo Takahashi, Morihito Okada, et al.
Japanese Journal of Clinical Oncology|June 18, 2020
Real-world use of osimertinib for epidermal growth factor receptor T790M-positive non-small cell lung cancer in JapanYuichiro Ohe, Terufumi Kato, Fumikazu Sakai, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 14, 2020
Real-World Evaluation of Factors for Interstitial Lung Disease Incidence and Radiologic Characteristics in Patients With EGFR T790M-positive NSCLC Treated With Osimertinib in JapanAkihiko Gemma, Masahiko Kusumoto, Fumikazu Sakai, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 8, 2014
EGFR mutation testing practices within the Asia Pacific region: results of a multicenter diagnostic surveyYasushi Yatabe, Keith M Kerr, Ahmad Utomo, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Ecology|July 18, 2013
A semiparametric Bayesian method for detecting Allee effectsMasatoshi Sugeno, Stephan B Munch
Ecological Applications : a Publication of the Ecological Society of America|July 20, 2013
A semiparametric Bayesian approach to estimating maximum reproductive rates at low population sizesMasatoshi Sugeno, Stephan B Munch
Diabetes, Obesity & Metabolism|June 20, 2023
Safety/tolerability, efficacy and pharmacokinetics of 600-μg cotadutide in Japanese type 2 diabetes patients with a body mass index of 25 kg/m<sup>2</sup> or higher: A phase I, randomized, double-blind, placebo-controlled studyMichiko Asano, Akiko Sekikawa, Masatoshi Sugeno, et al.
Cancer Treatment and Research Communications|April 9, 2024
Safety, tolerability, pharmacokinetics, and antitumor activity of adavosertib in Japanese patients with advanced solid tumors: A phase I, open-label studyShunsuke Kondo, Yuki Katsuya, Kan Yonemori, et al.
The Oncologist|June 7, 2022
Phase I Study of Tremelimumab Monotherapy or in Combination With Durvalumab in Japanese Patients With Advanced Solid Tumors or Malignant MesotheliomaYutaka Fujiwara, Yasuo Takahashi, Morihito Okada, et al.
Japanese Journal of Clinical Oncology|June 18, 2020
Real-world use of osimertinib for epidermal growth factor receptor T790M-positive non-small cell lung cancer in JapanYuichiro Ohe, Terufumi Kato, Fumikazu Sakai, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 14, 2020
Real-World Evaluation of Factors for Interstitial Lung Disease Incidence and Radiologic Characteristics in Patients With EGFR T790M-positive NSCLC Treated With Osimertinib in JapanAkihiko Gemma, Masahiko Kusumoto, Fumikazu Sakai, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 8, 2014
EGFR mutation testing practices within the Asia Pacific region: results of a multicenter diagnostic surveyYasushi Yatabe, Keith M Kerr, Ahmad Utomo, et al.
Pageof 1